CHICAGO, May 14, 2024
/PRNewswire/ -- Biopharmaceutical Process Analytical Technology
Market in terms of revenue was estimated to be worth
$1.2 billion in 2024 and is poised to
reach $2.6 billion by 2029, growing
at a CAGR of 16.0% from 2024 to 2029 according to a new report by
MarketsandMarkets™.
The global embrace of Process Analytical Technologies (PAT) is
propelled by heightened research investment from biopharmaceutical
firms, rigorous regulatory criteria for drug safety, improvements
in drug quality, and technological advancements.
Download an Illustrative overview:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=95920337
Browse in-depth TOC on "Biopharmaceutical Process Analytical
Technology Market"
168 - Tables
52 - Figures
255 -
Pages
Biopharmaceutical Process Analytical Technology
Market Scope:
Report
Coverage
|
Details
|
Market Revenue in
2024
|
$1.2 billion
|
Estimated Value by
2029
|
$2.6 billion
|
Growth Rate
|
Poised to grow at a
CAGR of 16.0%
|
Market Size Available
for
|
2022–2029
|
Forecast
Period
|
2024–2029
|
Forecast
Units
|
Value (USD
Billion)
|
Report
Coverage
|
Revenue Forecast,
Competitive Landscape, Growth Factors, and Trends
|
Segments
Covered
|
Type, Product Type,
Mode, Application, and Region
|
Geographies
Covered
|
North America, Europe,
Asia Pacific, Latin America, Middle East and Africa
|
Report
Highlights
|
Updated financial
information / product portfolio of players
|
Key Market
Opportunities
|
Healthcare costs are on
the rise in developing nations
|
Key Market
Drivers
|
Increasing demand for
enhancing the quality of manufacturing processes
|
Liquid chrpmatography/HPLC segment to register significant
growth rate over the forecast period of 2024-2029.
Based on the type, the global biopharmaceutical process
analytical market has been classified into segments— liquid
chromatography/HPLC, Gas chromatography, mass spectrometry,
real-time PCR/QPCR, NGS, NMR spectroscopy, raman spectroscopy,
infrared spectroscopy, particle counters and imaging, differential
light scattering, and other techniques. Liquid chromatography/HPLC
segment is anticipated to register significant growth. The
wide-ranging use of chromatography within the biopharmaceutical
sector, spanning tasks such as quantifying pharmaceutical
compounds, identifying pathogens, measuring proteins, and
supporting biochemistry and biophysics investigations, emphasizes
its significance. Moreover, stringent regulatory standards
governing drug development and safety play a significant role in
driving its global growth.
Analyzers segment accounted for the largest share of the
biopharmaceutical process analytical technology, by product type
market in 2023.
Based on product type, Analyzers segment dominates the
biopharmaceutical process analytical technology market, and the
trend is expected to continue over the forecast period. In 2023,
This sector claimed the largest share due to advancements in
process analytical techniques, which provide operational efficiency
and decrease process cycle times.
Online analysis segment dominated the market in terms of
measurement, in 2023.
Based on mode, In 2023, the dominant segment in the
biopharmaceutical process analytical technology tools market was
online analysis. The swift processing and dependable outcomes were
credited to the efficient monitoring of crucial process parameters
(CPP) throughout drug development and manufacturing. A range of
analytical methods, such as on-line, in-line, at-line, and off-line
approaches, were utilized to effectively analyze CPP.
North America market to hold
major share in the market during the forecast period.
Based on region, North America,
comprising the US and Canada,
accounted for the largest share of the global biopharmaceutical
process analytical technology market in 2023. The primary factors
fueling this market encompass the availability of research funding,
stringent regulations overseeing drug development, and the
increasing prevalence of conferences, discussions, symposiums, and
seminars centered around analytical technologies.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=95920337
Biopharmaceutical Process Analytical Technology Market
Dynamics:
Drivers:
- Increasing demand for enhancing the quality of manufacturing
processes
Restraints:
- High cost of PAT deployment
Opportunities:
- Healthcare costs are on the rise in developing nations
Challenge:
- Lack of skilled professionals
Key Market Players of Biopharmaceutical Process
Analytical Technology Industry:
As of 2023, prominent players in the biopharmaceutical process
analytical technology market are Waters Corporation (US), Thermo
Fisher Scientific, Inc. (US), Danaher Corporation (US), Agilent
Technologies, Inc. (US), Shimadzu Corporation (Japan), Bruker Corporation (US), Emerson
Electric Co. (US), ABB Ltd. (Switzerland), PerkinElmer, Inc. (US),
Mettler-Toledo International Inc. (US), and Carl Zeiss AG (Germany), among others.
A breakdown of the primary participants referred to for this
report is provided below:
- By Company Type: Tier 1 30%, Tier 2–42%, and Tier 3– 28%
- By Designation: C-level–14%, D Level–10%, and Others–76%
- By Region: North America–40%, Europe–30%, Asia Pacific–22%,
Latin America–6%, and the Middle
East & Africa–2%
Get 10% Free Customization on this Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=95920337
Recent Developments of Biopharmaceutical Process Analytical
Technology Industry:
- In Feb 2024, Thermo Fisher
Scientific Inc. introduced the Thermo Scientific Dionex Inuvion Ion
Chromatography (IC) system, aimed at simplifying, and enhancing ion
analysis across laboratories of varying scales. This innovative
analytical instrument offers easy reconfiguration, serving as a
comprehensive solution for the precise determination of ionic and
small polar compounds, ensuring consistent and reliable
results.
- In April 2022, Thermo Fisher
Scientific Inc. has introduced the Ramina Process Analyzer, a Raman
spectroscopic analyzer aimed at simplifying Raman spectroscopy
measurements to enhance user accessibility by reducing
complexity.
- In June 2021, Agilent
Technologies Inc. launched three InfinityLab Bio LC systems have
been introduced by the company, tailored to address the increasing
demands of the biopharmaceutical sector.
Biopharmaceutical Process Analytical Technology Market - Key
Benefits of Buying the Report:
The report will enable established firms as well as
entrants/smaller firms to gauge the pulse of the market, which, in
turn, would help them to garner a larger market share. Firms
purchasing the report could use one or a combination of the
below-mentioned strategies to strengthen their market presence.
This report provides insights on the following
pointers:
- Market Penetration: Comprehensive information on the product
portfolios offered by the top players in the biopharmaceutical
process analytical technology market
- Product Development/Innovation: Detailed insights on the
upcoming trends, R&D activities, and product launches in the
biopharmaceutical process analytical technology market
- Market Development: Comprehensive information on lucrative
emerging regions
- Market Diversification: Exhaustive information about new
products, growing geographies, and recent developments in the
biopharmaceutical process analytical technology market
- Competitive Assessment: In-depth assessment of market segments,
growth strategies, revenue analysis, and products of the leading
market players.
Related Reports:
Biomarkers Market - Global Forecasts to 2028
Epigenetics Market - Global Forecasts to 2028
Preimplantation Genetic Testing Market - Global Forecasts
to 2028
Molecular Diagnostics Market - Global Forecasts to 2028
Life Science Instrumentation Market - Global Forecasts to
2028
Get access to the latest updates on Biopharmaceutical Process
Analytical Technology Companies and Biopharmaceutical Process
Analytical Technology Industry
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's
best management consulting firms by Forbes, as per their recent
report.
MarketsandMarkets™ is a blue ocean alternative in growth
consulting and program management, leveraging a man-machine
offering to drive supernormal growth for progressive organizations
in the B2B space. We have the widest lens on emerging technologies,
making us proficient in co-creating supernormal growth for
clients.
Earlier this year, we made a formal transformation into one of
America's best management consulting firms as per a survey
conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are
substituting existing revenue streams in this decade alone. We work
with clients on growth programs, helping them monetize this
$25 trillion opportunity through our
service lines - TAM Expansion, Go-to-Market (GTM) Strategy to
Execution, Market Share Gain, Account Enablement, and Thought
Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several
Forbes Global 2000 B2B companies - helping them stay relevant in a
disruptive ecosystem. Our insights and strategies are molded by our
industry experts, cutting-edge AI-powered Market Intelligence
Cloud, and years of research. The KnowledgeStore™ (our Market
Intelligence Cloud) integrates our research, facilitates an
analysis of interconnections through a set of applications, helping
clients look at the entire ecosystem and understand the revenue
shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us
on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish
Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo:
https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
View original
content:https://www.prnewswire.com/news-releases/biopharmaceutical-process-analytical-technology-market-worth-2-6-billion--marketsandmarkets-302144537.html
SOURCE MarketsandMarkets